EVast Bio Inc.
February 26, 2024
Multiple Therapeutics
EVast Bio is a US-based, clinical-stage biotech born as a result of ground-breaking work at C4C (https://c4c.cl). EVast Bio is devoted to exploring the vast potential of small Extracellular Vesicles (EVs) as nanotherapeutics and targeted delivery systems, enabling treatments that set new standards in medical innovation.